http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2464990-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df3cd2337ab586f967a23dfda5d945e6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-34 |
| filingDate | 2011-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d15ece1a4cfed91619c2d423084c6fd6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b344fd7abd3d0ea84eb424d13407ef7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bdcb845fb739903fe496cd47a075351 |
| publicationDate | 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2464990-C1 |
| titleOfInvention | Agent showing anxiolytic action |
| abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to medicine, namely clinical pharmacology, and may be used for pharmacological correction of the CNS disease, and concerns the agents showing anxiolytic action. The ingredients of the composition have the following relation, wt %: Magnesium sulphate 77.76835-50.22505; Ferric (II) sulphate 13.73-30.27; Copper (II) sulphate 8.50-19.50; Chromium (III) chloride 0.00165-0.00495. n EFFECT: developing the agents showing anxiolytic action. n 3 ex, 1 tbl |
| priorityDate | 2011-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.